• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用作免疫原的合成肽(包括一种疟疾肽)的构象限制。

The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.

作者信息

Satterthwait A C, Arrhenius T, Hagopian R A, Zavala F, Nussenzweig V, Lerner R A

机构信息

Research Institute of Scripps Clinic, La Jolla, California 92037.

出版信息

Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):565-72. doi: 10.1098/rstb.1989.0036.

DOI:10.1098/rstb.1989.0036
PMID:2569211
Abstract

A new strategy is advanced for the conformational restriction of peptidyl immunogens. Our approach is to replace putative amide-amide hydrogen bonds with covalent hydrogen-bond mimics. Because on average every other amino acid in a protein engages in this bond, the syntheses of diversely shaped peptides can be contemplated. Synthetic methods for introducing a potential hydrogen-bond mimic into a peptide with alpha-helical potential is reported and the structural consequences are discussed. The replacement of the hydrogen bond with a chemical link will modify as well as shape the peptide. To explore the consequences of these changes, a potential synthetic vaccine for malaria, the repeating tetrapeptide Asn-Pro-Asn-Ala, was conformationally restricted. Antibodies to the shaped malarial peptide showed a strong cross reaction with Plasmodium falciparum sporozoites.

摘要

一种用于肽基免疫原构象限制的新策略被提出。我们的方法是用共价氢键模拟物取代假定的酰胺-酰胺氢键。由于蛋白质中平均每隔一个氨基酸就参与这种键合,因此可以设想合成各种形状的肽。报道了将潜在的氢键模拟物引入具有α-螺旋潜力的肽中的合成方法,并讨论了其结构后果。用化学连接取代氢键将修饰并塑造肽。为了探索这些变化的后果,对一种潜在的疟疾合成疫苗——重复四肽天冬酰胺-脯氨酸-天冬酰胺-丙氨酸进行了构象限制。针对这种形状的疟疾肽产生的抗体与恶性疟原虫子孢子表现出强烈的交叉反应。

相似文献

1
The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.用作免疫原的合成肽(包括一种疟疾肽)的构象限制。
Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):565-72. doi: 10.1098/rstb.1989.0036.
2
Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond.用氢键的共价替代物对肽基免疫原进行构象限制。
Vaccine. 1988 Apr;6(2):99-103. doi: 10.1016/s0264-410x(88)80007-0.
3
The conformational restriction of synthetic vaccines for malaria.疟疾合成疫苗的构象限制
Bull World Health Organ. 1990;68 Suppl(Suppl):17-25.
4
Construction of immunogens for synthetic malaria vaccines.合成疟疾疫苗免疫原的构建。
Biochem Biophys Res Commun. 1988 May 31;153(1):31-8. doi: 10.1016/s0006-291x(88)81185-9.
5
Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR.
Biochemistry. 1990 Aug 28;29(34):7828-37. doi: 10.1021/bi00486a008.
6
Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development.恶性疟原虫25kD表面蛋白中被传播阻断单克隆抗体识别的肽序列的鉴定:对合成疫苗开发的意义
Parasite Immunol. 1989 Jul;11(4):425-8. doi: 10.1111/j.1365-3024.1989.tb00679.x.
7
The development of molecular vaccines against malaria sporozoites.抗疟原虫子孢子分子疫苗的研发。
Adv Exp Med Biol. 1989;251:295-313. doi: 10.1007/978-1-4757-2046-4_27.
8
Conformation and immunogenicity of engineered repeating segment of the circumsporozoite surface protein of Plasmodium falciparum.
Mol Biochem Parasitol. 1990 Jan 1;38(1):135-40. doi: 10.1016/0166-6851(90)90213-6.
9
Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.恶性疟原虫(NANP)序列作为多抗原肽缺乏H-2限制性。
Eur J Immunol. 1991 Sep;21(9):2273-6. doi: 10.1002/eji.1830210941.
10
The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.小鼠对恶性疟原虫环子孢子重复表位无载体合成聚合物的抗体反应受I-Ab限制:对疟疾疫苗的潜在影响。
J Immunol. 1986 Nov 1;137(9):2952-5.

引用本文的文献

1
T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamics.通过 NMR 和分子动力学研究抗疟肽的 T1BT*结构。
Malar J. 2013 Mar 18;12:104. doi: 10.1186/1475-2875-12-104.
2
Antigenic diversity and immune evasion by malaria parasites.疟原虫的抗原多样性与免疫逃避
Clin Diagn Lab Immunol. 2004 Nov;11(6):987-95. doi: 10.1128/CDLI.11.6.987-995.2004.
3
Malaria vaccines.
J Clin Immunol. 1996 Jul;16(4):183-9. doi: 10.1007/BF01541223.
4
Antigen mobility in the combining site of an anti-peptide antibody.抗原在抗肽抗体结合位点中的移动性。
Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7968-72. doi: 10.1073/pnas.88.18.7968.
5
Protein antigenicity.蛋白质抗原性
Mol Biol Rep. 1992 Jun;16(3):133-8. doi: 10.1007/BF00464700.